Evidence map›Paper›PMID 41302477›Full record

ArticleMolecules (Basel, Switzerland)2025

Novel 5-Aryl-[1,2,4]triazoloquinazoline Fluorophores: Synthesis, Comparative Studies of the Optical Properties and ICT-Based Sensing Application.

Alexandra E Kopotilova, Julia V Permyakova, Ekaterina S Starnovskaya, Tatyana N Moshkina, Alexander S Novikov, Pavel A Slepukhin, Emiliya V Nosova

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandra E KopotilovaOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.
Julia V PermyakovaOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.
Ekaterina S StarnovskayaOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.
Tatyana N MoshkinaOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.
Alexander S NovikovInstitute of Chemistry, Saint Petersburg State University, 7/9 Universitetskaya Nab., Saint Petersburg 199034, Russia.ORCID 0000-0001-9913-5324
Pavel A SlepukhinOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.
Emiliya V NosovaOrganic and Biomolecular Chemistry Department, Chemical Technology Institute, Ural Federal University, Mira St. 19, Ekaterinburg 620002, Russia.ORCID 0000-0002-0177-1582

Funding

Ministry of Science and Higher Education of the Russian Federation (Ural Federal University Program of Development within the Priority-2030 Program) C2-29
6 · The paper itself

Abstract

Novel tricyclic fluorophores were obtained from 2-aryl-[1,2,4]triazolo[1,5-c]quinazoline-5(6

Indexed as

electronic-structure calculationsluminescencenitrogen heterocyclespush-pull quinazolinestwo-photon absorption

Identifiers

PMID41302477
PMCPMC12655076

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.